STOCK TITAN

[144] Astera Labs, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Astera Labs' Form 144 discloses a proposed sale of 26,000 common shares on NASDAQ through broker Stifel, with an aggregate market value of $4,556,737.00 and the issuer reported 162,150,000 shares outstanding. The filing shows the shares were acquired in private placements: 1,000 on 05/17/2022 and 25,000 on 11/08/2019. A related sale by Stefan A Dyckerhoff of 26,000 shares on 08/07/2025 for $4,508,959.00 is also listed. The notice includes the seller's representation that they do not possess undisclosed material adverse information and contains the standard legal warning about intentional misstatements.

Il Form 144 di Astera Labs segnala una proposta di vendita di 26,000 azioni ordinarie su NASDAQ tramite il broker Stifel, con un valore di mercato complessivo di $4,556,737.00 e l'emittente ha riportato 162,150,000 azioni in circolazione. La documentazione indica che le azioni sono state acquisite in collocamenti privati: 1,000 il 05/17/2022 e 25,000 il 11/08/2019. È inoltre elencata una vendita correlata da parte di Stefan A Dyckerhoff di 26,000 azioni il 08/07/2025 per $4,508,959.00. L'avviso include la dichiarazione del venditore di non essere in possesso di informazioni negative materiali non divulgate e contiene l'avvertimento legale standard riguardo a dichiarazioni intenzionalmente false.

El Form 144 de Astera Labs revela una propuesta de venta de 26,000 acciones ordinarias en NASDAQ a través del corredor Stifel, con un valor de mercado agregado de $4,556,737.00 y el emisor informó 162,150,000 acciones en circulación. La presentación muestra que las acciones se adquirieron en colocaciones privadas: 1,000 el 05/17/2022 y 25,000 el 11/08/2019. También figura una venta relacionada por parte de Stefan A Dyckerhoff de 26,000 acciones el 08/07/2025 por $4,508,959.00. El aviso incluye la declaración del vendedor de que no posee información adversa material no divulgada y contiene la advertencia legal estándar sobre declaraciones intencionalmente falsas.

Astera Labs의 Form 144는 중개인 Stifel을 통해 NASDAQ에서 26,000 보통주 매각을 제안했음을 공개하며, 총 시가총액은 $4,556,737.00이고 발행사는 162,150,000주를 발행주식수로 신고했습니다. 신청서에는 해당 주식이 사모 발행으로 취득되었음을 나타내며, 그 내역은 05/17/20221,000주, 11/08/201925,000주입니다. 또한 Stefan A Dyckerhoff08/07/202526,000주 매각(금액: $4,508,959.00)도 기재되어 있습니다. 통지문에는 판매자가 공개되지 않은 중대한 불리한 정보를 보유하고 있지 않다는 진술과 고의적 허위진술에 대한 표준 법적 경고가 포함되어 있습니다.

Le Form 144 d'Astera Labs révèle une cession envisagée de 26,000 actions ordinaires sur le NASDAQ via le courtier Stifel, pour une valeur de marché totale de $4,556,737.00, et l'émetteur a déclaré 162,150,000 actions en circulation. Le dossier indique que les actions ont été acquises lors de placements privés : 1,000 le 05/17/2022 et 25,000 le 11/08/2019. Une cession liée par Stefan A Dyckerhoff de 26,000 actions le 08/07/2025 pour $4,508,959.00 est également mentionnée. L'avis inclut la déclaration du vendeur selon laquelle il ne détient pas d'informations défavorables matérielles non divulguées et contient l'avertissement juridique standard concernant les fausses déclarations intentionnelles.

Das Form 144 von Astera Labs legt einen geplanten Verkauf von 26,000 Stammaktien an der NASDAQ über den Broker Stifel offen, mit einem aggregierten Marktwert von $4,556,737.00. Der Emittent meldete 162,150,000 ausstehende Aktien. Die Einreichung weist aus, dass die Aktien in Privatplatzierungen erworben wurden: 1,000 am 05/17/2022 und 25,000 am 11/08/2019. Ebenfalls aufgeführt ist ein damit zusammenhängender Verkauf durch Stefan A Dyckerhoff von 26,000 Aktien am 08/07/2025 für $4,508,959.00. Die Mitteilung enthält die Darstellung des Verkäufers, dass er nicht im Besitz nicht offengelegter wesentlicher nachteiliger Informationen ist, sowie die übliche rechtliche Warnung vor vorsätzlichen Falschangaben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Form 144 discloses a proposed sale of 26,000 ALAB common shares via Stifel on NASDAQ.

The filing specifies the intended transaction size (26,000 shares) and the stated aggregate market value ($4,556,737.00), plus the company's outstanding share count (162,150,000). It also documents prior acquisitions by the filer through private placements and a recent sale by Stefan A Dyckerhoff on 08/07/2025. The form contains the seller's certification regarding material nonpublic information, consistent with normal Rule 144 disclosures.

TL;DR: Filing includes required seller representations and a transaction record; it documents acquisition dates and a recent sale.

The notice includes explicit acquisition history (private placements on 11/08/2019 and 05/17/2022), the broker on record (Stifel), and the seller's declaration about undisclosed material information. Those elements align with Rule 144 procedural disclosure requirements and provide a clear audit trail for the reported transactions.

Il Form 144 di Astera Labs segnala una proposta di vendita di 26,000 azioni ordinarie su NASDAQ tramite il broker Stifel, con un valore di mercato complessivo di $4,556,737.00 e l'emittente ha riportato 162,150,000 azioni in circolazione. La documentazione indica che le azioni sono state acquisite in collocamenti privati: 1,000 il 05/17/2022 e 25,000 il 11/08/2019. È inoltre elencata una vendita correlata da parte di Stefan A Dyckerhoff di 26,000 azioni il 08/07/2025 per $4,508,959.00. L'avviso include la dichiarazione del venditore di non essere in possesso di informazioni negative materiali non divulgate e contiene l'avvertimento legale standard riguardo a dichiarazioni intenzionalmente false.

El Form 144 de Astera Labs revela una propuesta de venta de 26,000 acciones ordinarias en NASDAQ a través del corredor Stifel, con un valor de mercado agregado de $4,556,737.00 y el emisor informó 162,150,000 acciones en circulación. La presentación muestra que las acciones se adquirieron en colocaciones privadas: 1,000 el 05/17/2022 y 25,000 el 11/08/2019. También figura una venta relacionada por parte de Stefan A Dyckerhoff de 26,000 acciones el 08/07/2025 por $4,508,959.00. El aviso incluye la declaración del vendedor de que no posee información adversa material no divulgada y contiene la advertencia legal estándar sobre declaraciones intencionalmente falsas.

Astera Labs의 Form 144는 중개인 Stifel을 통해 NASDAQ에서 26,000 보통주 매각을 제안했음을 공개하며, 총 시가총액은 $4,556,737.00이고 발행사는 162,150,000주를 발행주식수로 신고했습니다. 신청서에는 해당 주식이 사모 발행으로 취득되었음을 나타내며, 그 내역은 05/17/20221,000주, 11/08/201925,000주입니다. 또한 Stefan A Dyckerhoff08/07/202526,000주 매각(금액: $4,508,959.00)도 기재되어 있습니다. 통지문에는 판매자가 공개되지 않은 중대한 불리한 정보를 보유하고 있지 않다는 진술과 고의적 허위진술에 대한 표준 법적 경고가 포함되어 있습니다.

Le Form 144 d'Astera Labs révèle une cession envisagée de 26,000 actions ordinaires sur le NASDAQ via le courtier Stifel, pour une valeur de marché totale de $4,556,737.00, et l'émetteur a déclaré 162,150,000 actions en circulation. Le dossier indique que les actions ont été acquises lors de placements privés : 1,000 le 05/17/2022 et 25,000 le 11/08/2019. Une cession liée par Stefan A Dyckerhoff de 26,000 actions le 08/07/2025 pour $4,508,959.00 est également mentionnée. L'avis inclut la déclaration du vendeur selon laquelle il ne détient pas d'informations défavorables matérielles non divulguées et contient l'avertissement juridique standard concernant les fausses déclarations intentionnelles.

Das Form 144 von Astera Labs legt einen geplanten Verkauf von 26,000 Stammaktien an der NASDAQ über den Broker Stifel offen, mit einem aggregierten Marktwert von $4,556,737.00. Der Emittent meldete 162,150,000 ausstehende Aktien. Die Einreichung weist aus, dass die Aktien in Privatplatzierungen erworben wurden: 1,000 am 05/17/2022 und 25,000 am 11/08/2019. Ebenfalls aufgeführt ist ein damit zusammenhängender Verkauf durch Stefan A Dyckerhoff von 26,000 Aktien am 08/07/2025 für $4,508,959.00. Die Mitteilung enthält die Darstellung des Verkäufers, dass er nicht im Besitz nicht offengelegter wesentlicher nachteiliger Informationen ist, sowie die übliche rechtliche Warnung vor vorsätzlichen Falschangaben.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ALAB Form 144 disclose?

The filing notifies a proposed sale of 26,000 common shares of Astera Labs (ALAB) via broker Stifel on NASDAQ with aggregate market value $4,556,737.00.

Who is the seller named in the Form 144?

The filing lists Stefan A Dyckerhoff as a related seller and shows a reported sale by him of 26,000 shares on 08/07/2025 for $4,508,959.00.

When is the approximate sale date and which exchange is listed?

The filing lists the approximate date of sale as 08/08/2025 and the exchange as NASDAQ.

How were the shares being sold originally acquired?

The shares were acquired in private placements: 25,000 shares on 11/08/2019 and 1,000 shares on 05/17/2022, with payment noted as cash.

How many shares does the issuer report outstanding?

The filing shows 162,150,000 shares outstanding for the issuer.
ASTERA LABS INC

NASDAQ:ALAB

ALAB Rankings

ALAB Latest News

ALAB Latest SEC Filings

ALAB Stock Data

28.99B
142.59M
13.54%
73.87%
6.77%
Semiconductors
Semiconductors & Related Devices
Link
United States
SAN JOSE